Clinical Trial Update: Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms

View source ↗

Summary

Completed trial evaluating whether measuring fractional exhaled nitric oxide (FeNO) with the NIOX MINO device can help identify asthma in patients with prolonge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Aerocrine AB | Conditions: Asthma | Status: COMPLETED | Results posted: 2013-08-30